City

Houston (1)

Montreal (1)

Overall Status

Recruiting (1)

Unknown status (1)

Withdrawn (1)

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Baylor College of Medicine (1)

Ciusss de L'Est de l'Ile de Montreal (1)

Virginia Commonwealth University (1)

Collaborator

Center for Cell and Gene Therapy, Baylor College of Medicine (1)

Gilead Sciences (1)

The Methodist Hospital Research Institute (1)

Study Documents

Intervention Type

drug (2)

biological (1)

genetic (1)

Funder Type

Other (3)

Study Type

Interventional (3)

relapsed cll

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston

Recruiting

Refractory B-Cell Non-Hodgkin Lymphoma
+4 more

CD19.CAR-aNKT cells
+2 more

Houston, Texas
+1 more

Aug 19, 2022

Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)

Withdrawn

Chronic Lymphocytic Leukemia
+8 more

Dose combination 1-1
+5 more

(no location specified)

Nov 1, 2021

Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL Trial in Montreal (GLIDE)

Unknown status

Hematologic Cancer
+8 more

GLIDE

Montreal, Quebec, Canada

CIUSSS d l'Est-de-l'Île-de-Montréal

Dec 4, 2017